Indeed, a recent study by our lab found that CTDP1 knockdown not only increases the sensitivity of breast cell lines to DNA inter-strand crosslink (ICL)-inducing agents but also compromises the growth of breast cancer cells in vitro and in vivo (Hu et al., 2019). Here, CTDP1 is linked to breast carcinoma.